EU Human Insulin Drugs Market, by Product type (Basal or Long-acting Insulins, Bolus or Fast-acting Insulins, Traditional Human Insulins, Combination Insulins, and Biosimilar Insulins) Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138287
- Pages: 200
-
Format:
Report Overview
The EU Human Insulin Drugs market size stood at round USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 4.3% during the forecast period
Human insulin, whether produced by recombinant DNA techniques (biosynthetic, insulin crb) or enzymatic modification of porcine insulin (semisynthetic, insulin emp) is equivalent in biological activity to porcine insulin following intravenous administration. Slight differences between human and porcine insulin in hypoglycaemic activity after subcutaneous injection appear to be related to differences in absorption, and are unlikely to be of major clinical importance
Market Drivers
Prevalence of diabetes among all age groups in the European region is increasing mainly due to obesity, unhealthy diet and physical inactivity.The prevalence of autoimmune Type 1 Diabetes is also rising in Europe, and as per sources, Europe has the highest number of children with Type 1 Diabetes. United Kingdom has majority of type-1 diabetes cases among the European region
1. EU Human Insulin Market Overview
A. Market Size
2. EU Human Insulin Growth Drivers
I. Prevalence of diabetes among all age groups
II. The prevalence of autoimmune Type 1 Diabetes is also rising in Europe
3. EU Human Insulin Market Segmentation.
A. By Product Type
I. Basal or Long-acting Insulins
II. Bolus or Fast-acting Insulins
III. Traditional Human Insulins
IV. Combination Insulins
V. Biosimilar Insulins
4. EU Human Insulin Market Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Novo Nordisk Company overview, Product & Services, Strategies & Financials
B. Sanofi Company overview, Product & Services, Strategies & Financials
C. Eli-Lilly Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Market Opportunities and Future Trends
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
